Market Overview

UPDATE: Bank Of America Upgrades Carnival On Improving Trends


In a note released Thursday morning, Bank of America analyst Nicholas Thomas upgraded shares of Carnival (NYSE: CCL) from Neutral to Buy and raised the price objective from $42.90 to $45.50.

Thomas began by noting that the stock has fallen 15 percent year to date, shifting its value from 19x to 15x fiscal-year 2015 P/E. Additionally, he said the company's failure to produce positive net yield growth in the third quarter was "bad for sentiment." However, he remains confident that the fourth quarter of 2014 will represent an inflection point in yield.

As an additional positive, Thomas noted Carnival's new CEO says there is significant room for cost and revenue synergies from cross-brand operational efficiencies.

"We fundamentally believe this asset under more intense and improved stewardship has both the market position and scale to derive ROIC in excess of WACC and mush improved margins," Thomas said. "In 2008 (pre-crisis) margins were 18 percent vs. 10 percent currently and ROIC was 11 percent vs. five percent currently. It may take time, but we continue to believe Carnival Corporation can return to these levels in the medium term."

Latest Ratings for CCL

Jul 2019MaintainsHold
Jul 2019DowngradesBuyHold
Jun 2019MaintainsHold

View More Analyst Ratings for CCL
View the Latest Analyst Ratings

Posted-In: Bank of America Nicholas ThomasAnalyst Color Upgrades Price Target Analyst Ratings


Related Articles (CCL)

View Comments and Join the Discussion!

Latest Ratings

HSKACanaccord GenuityMaintains75.0
AVGOMorgan StanleyMaintains265.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Noble Financial Initiates Heron Therapeutics At Buy

Evercore Group Has Continued Positive Outlook On Applied Micro Circuits